It’s everyone’s favorite time of the year. No, not college football (still stings to think about that), but HRSA’s annual recertification for hospitals. This year, HRSA has provided updated registration and recertification requirements. This blog is not intended to cover every aspect of recertification, but a few tips and thoughts as you prepare to getRead More
As the second largest covered entity (CE) type after hospitals, Federally Qualified Health Center (FQHC) specific 340B information and application can often lag behind. Within the last few years, Apexus begun offering 340B University OnDemand for FQHCs, as well as periodically offering 340B University Live for FQHCs only, in conjunction National Association Community Health Center (NACHC) conferences.Read More
Several Apexus frequently asked questions (FAQs) have been released recently that have been interpreted to mean hospital 340B CEs will no longer need to wait to use 340B drugs at new or relocated provider-based clinics. Turnkey is just as pleasantly surprised as you are! Below is an attempt to clarify implications of these FAQs andRead More
Some call it Novel Coronavirus SARS-CoV-2. Others call it Corona Virus disease of 2019. Many like to say Covid-19 or just plain Corona. Anyway you say it, it brings up many emotions for nearly every American. Everyone in our society has been impacted in some way. The virus has thrown the Healthcare industry into nearRead More
Unless you have been living under a rock the past several months, you know that the COVID-19 Public Health Emergency (PHE) has dramatically impacted how both hospital and clinic providers strategize to provide healthcare to patients, including remotely via telehealth services (aka telemedicine). Given COVID-19 travel and gathering restrictions, it is obvious why the useRead More
For those of us in the 340B program trenches, it feels like we are constantly under assault from our legislatures (e.g., Senate and House bills with detrimental effects on 340B), regulatory agencies (e.g., CMS reimbursement, HHS/HRSA interpretations of the law), drug manufacturer groups (e.g., PhRMA doing anything possible to dismantle the program), and even theRead More
The Turnkey team of Rich and Rich clearly have extensive hospital experience with 340B and were able to quickly understand our operational issues and provide clear recommendations. When our team had questions months later they promptly responded to each request with thoughtful and specific advice.
We have contracted Turnkey Rx Solutions for almost a year now. We're very impressed with the work they have been able to provide us. They understand the high standards that our health system has and have been the efficient delivering. I highly recommend working with them.
Turnkey Solutions was well prepared for our mock audit and knew just what questions to ask and where to look for improvement opportunities. They easily found the needles in the haystack and took the time to understand our practice to make the best suggestions for improvement. ... It was a delight to work with them and I will contract with them again in the future.
We have been extremely satisfied with the assistance Turnkey Pharmacy Solutions has provided to us as our 340B program has expanded. We have worked with Rich and Rob and find them to be extremely knowledgeable, thorough, and personable. Their mission was to identify and minimize any potential risk areas within our 340B program. As a result, we feel very confident in our processes.
TurnKey is very knowledgeable of the 340B Program. They identified potential risk areas for our organization and provided us with the necessary corrective action. Thanks to TurnKey, we identified and addressed those risk areas and are now better prepared for a HRSA Audit.
The information and resources that were provided through the audit process with Turnkey have been invaluable. We will definitely continue to work with them in the future to ensure our program compliance.
Together, we can get your 340B Program HRSA compliant!